TAM
ESPR

Tiverton Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Tiverton Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$635K Sell
17,327
-284
-2% -$11.3K 0.02% 348
2019
Q2 		$819K Sell
17,611
-4,909
-22% -$231K 0.03% 299
2019
Q1 		$904K Buy
22,520
+940
+4% +$42.2K 0.04% 254
2018
Q4 		$992K Sell
21,580
-4,206
-16% -$203K 0.06% 179
2018
Q3 		$1.14M Buy
25,786
+22,199
+619% +$1.02M 0.06% 190
2018
Q2 		$140K Sell
3,587
-30,593
-90% -$1.55M 0.01% 353
2018
Q1 		$2.47M Buy
34,180
+25,786
+307% +$1.89M 0.17% 107
2017
Q4 		$553K Sell
8,394
-5,823
-41% -$314K 0.03% 233
2017
Q3 		$713K Sell
14,217
-1,877
-12% -$90.5K 0.04% 160
2017
Q2 		$745K Sell
16,094
-5,231
-25% -$192K 0.04% 166
2017
Q1 		$753K Hold
21,325
– – 0.04% 170
2016
Q4 		$267K Hold
21,325
– – 0.02% 187
2016
Q3 		$295K Sell
21,325
-34,738
-62% -$394K 0.02% 155
2016
Q2 		$2.94M Sell
56,063
-53,297
-49% -$883K 0.12% 124
2016
Q1 		$1.85M Sell
109,360
-11,195
-9% -$180K 0.06% 141
2015
Q4 		$2.68M Sell
120,555
-15,000
-11% -$378K 0.09% 133
2015
Q3 		$3.2M Hold
135,555
– – 0.07% 136
2015
Q2 		$11.1M Buy
135,555
+25,455
+23% +$2.49M 0.22% 105
2015
Q1 		$10.2M Buy
+110,100
New +$7.11M 0.21% 103

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tiverton Asset Management's ESPR Position: Q3 2019 in Review

Tiverton Asset Management reduced its Esperion Therapeutics (ESPR) stake by 1.6% in Q3 2019, selling an estimated $11.3K and leaving 17,327 shares worth $635K. The position accounts for 0.02% of the portfolio, ranked #348.

Tiverton Asset Management first reported a position in ESPR in Q1 2015 and has held it in 19 quarters since. The position peaked at $11.1M in Q2 2015. 152 funds tracked by Wall St. Rank hold ESPR as of Q3 2019.

  • Tiverton Asset Management held 17,327 shares of Esperion Therapeutics worth $635K as of Q3 2019.
  • Tiverton Asset Management sold 284 Esperion Therapeutics shares in Q3 2019, an estimated $11.3K.
  • Esperion Therapeutics made up 0.02% of Tiverton Asset Management's portfolio in Q3 2019, its #348 holding.
  • Tiverton Asset Management first reported a position in Esperion Therapeutics in Q1 2015 and has held it in 19 quarters since.
  • Tiverton Asset Management's Esperion Therapeutics position peaked at $11.1M in Q2 2015.
  • 152 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.